Sr. Director, Global Head of Health Economics & Outcomes Research (Hybrid-Acton, MA or San Diego, CA)

Responsibilities

• Define and oversee the execution of Insulet's global HEOR strategy for current, in-market and future assets across all markets.
• Build and mature global HEOR capabilities that strengthen Insulet's leadership in demonstrating the health and economic added value of diabetes innovation and connected care. Ensure HEOR evidence is embedded early in clinical development plans and evolves through launch and lifecycle management.
• Build, expand and lead/mentor a high‑performing global HEOR team.
• Manage budgets, vendors, and compliance with HEOR guidelines.
• Lead enterprise-wide HEOR planning to support optimized, sustainable access and reimbursement/coverage decisions (including HTA reviews) of Insulet assets at value-based prices at launch & during their life cycle
• Oversee and drive the development and selection of economic and patient-reported outcomes (PRO) endpoints and instruments to be included in Insulet trials and Insulet-sponsored effectiveness research projects and real-world evidence (RWE) partnerships to drive differentiation and value perception.
• Ensure global evidence packages for Insulet assets support the needs of the various payer archetypes and HTA bodies across each of the markets Insulet (will) operate in.
• Strategically drive the early the economic value assessment and maximization for pipeline assets.
• Lead/oversee (the team) developing and updating a diverse suite of insights-driven economic models for each of the current and future Insulet solutions/target indications, as part of a set of global access-supporting deliverables developed for each of these assets.
• Plan and drive HEOR publication planning, submission and acceptance of publications of Insulet HEOR data, in collaboration with other stakeholders in the Insulet access community and medical affairs colleagues.
• Partner with the global HEMA segment leads, US and regional access teams to embed HEOR evidence into global, regional and local pricing,

Benefits

Additional Information

Job Summary The Senior Director & Global Head of Health Economics & Outcomes Research (HEOR) / Payer Evidence Generation at Insulet is a strategic leader tasked with defining and communicating the clinical, economic, and humanistic value of the Omnipod® portfolio and future innovations. Collaborating with various teams, including regional and local access, Medical Affairs, Clinical Development, commercial strategy, R&D, Digital Health, Commercial, and Government Affairs, this role is pivotal in enhancing payer value evidence and health technology assessment (HTA). Reporting to the VP of Global HEMA, the incumbent will lead a global team of experts in HEOR and real-world evidence (RWE) study design, epidemiology, biostatistics, patient-reported outcomes (PROs), and health economic modeling development and adaptation. Company Overview Insulet started in 2000 driven to achieve our mission of enabling our customers to enjoy simplicity, freedom and healthier lives through the use of our Omnipod® product platform. In the last two decades we have improved the lives of hundreds of thousands of patients who have insulin-requiring diabetes, by using innovative technology that is wearable, waterproof, and lifestyle accommodating. As market leader in our field, we are on an exciting trajectory of significant further growth and geographic expansion enabling us to reach more patients around the globe. We are looking for highly motivated, performance driven individuals who want to be part of further building our Global Health Economics & Market Access (HEMA) Capability and be at the forefront of our rapidly growing global footprint. We are looking to hire amazing people who are guided by shared values and desire to exceed customer expectations. Our continued success depends on it. Position Overview The Senior Director & Global Head of Health Economics & Outcomes Research (HEOR)/ Payer Evidence Generation is a global strategic leader responsible for defining and communicating the clinical, economic, and humanistic value of the Omnipod® portfolio and Insulet's future innovations, in partnership with members of the regional and local access community @ Insulet, Medical Affairs, Clinical Development, commercial strategy, R&D, Digital Health, Commercial, and Government Affairs. The incumbent will report to the VP of Global HEMA and will be the primary authority on payer value evidence and health technology assessment (HTA). They will oversee and lead a global capability/team of experts spanning HEOR/RWE study design and execution, epidemiology and biostats, PROs, and health‑economic modeling development and adaptation.

Your Match

How well this role fits your profile.

Company Intel

What employees say

Worked at insulet? Share your experience